In addition, patients with non-small cell lung cancer (NSCLC) had higher IGF1 and lower IGFBP-3 and IGFBP-7 serum and tumor tissue concentrations compared to patients with noncancerous lung diseases [17]. The gene discussed is IGF1; the disease is non-small cell lung carcinoma.